Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystem, and profoundly debilitating neuroimmune disease, probably of post-viral multifactorial etiology. Unfortunately, no accurate diagnostic or laboratory tests have been established, nor are any universally effective a...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-07-01
|
| Series: | Nutrients |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6643/13/8/2658 |
| _version_ | 1797522604987252736 |
|---|---|
| author | Jesús Castro-Marrero Maria Jose Segundo Marcos Lacasa Alba Martinez-Martinez Ramon Sanmartin Sentañes Jose Alegre-Martin |
| author_facet | Jesús Castro-Marrero Maria Jose Segundo Marcos Lacasa Alba Martinez-Martinez Ramon Sanmartin Sentañes Jose Alegre-Martin |
| author_sort | Jesús Castro-Marrero |
| collection | DOAJ |
| description | Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystem, and profoundly debilitating neuroimmune disease, probably of post-viral multifactorial etiology. Unfortunately, no accurate diagnostic or laboratory tests have been established, nor are any universally effective approved drugs currently available for its treatment. This study aimed to examine whether oral coenzyme Q10 and NADH (reduced form of nicotinamide adenine dinucleotide) co-supplementation could improve perceived fatigue, unrefreshing sleep, and health-related quality of life in ME/CFS patients. A 12-week prospective, randomized, double-blind, placebo-controlled trial was conducted in 207 patients with ME/CFS, who were randomly allocated to one of two groups to receive either 200 mg of CoQ10 and 20 mg of NADH (<i>n</i> = 104) or matching placebo (<i>n</i> = 103) once daily. Endpoints were simultaneously evaluated at baseline, and then reassessed at 4- and 8-week treatment visits and four weeks after treatment cessation, using validated patient-reported outcome measures. A significant reduction in cognitive fatigue perception and overall FIS-40 score (<i>p</i> < 0.001 and <i>p</i> = 0.022, respectively) and an improvement in HRQoL (health-related quality of life (SF-36)) (<i>p</i> < 0.05) from baseline were observed within the experimental group over time. Statistically significant differences were also shown for sleep duration at 4 weeks and habitual sleep efficiency at 8 weeks in follow-up visits from baseline within the experimental group (<i>p</i> = 0.018 and <i>p</i> = 0.038, respectively). Overall, these findings support the use of CoQ10 plus NADH supplementation as a potentially safe therapeutic option for reducing perceived cognitive fatigue and improving the health-related quality of life in ME/CFS patients. Future interventions are needed to corroborate these clinical benefits and also explore the underlying pathomechanisms of CoQ10 and NADH administration in ME/CFS. |
| first_indexed | 2024-03-10T08:31:47Z |
| format | Article |
| id | doaj.art-ff28776092144106a3a4899fa08ff446 |
| institution | Directory Open Access Journal |
| issn | 2072-6643 |
| language | English |
| last_indexed | 2024-03-10T08:31:47Z |
| publishDate | 2021-07-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Nutrients |
| spelling | doaj.art-ff28776092144106a3a4899fa08ff4462023-11-22T09:04:05ZengMDPI AGNutrients2072-66432021-07-01138265810.3390/nu13082658Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled TrialJesús Castro-Marrero0Maria Jose Segundo1Marcos Lacasa2Alba Martinez-Martinez3Ramon Sanmartin Sentañes4Jose Alegre-Martin5ME/CFS Research Unit, Division of Rheumatology, Vall d’Hebron Hospital Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainClinical Research Department, Vitae Health Innovation, Montmeló, 08160 Barcelona, SpainDepartment of Education, Generalitat de Catalunya, Sabadell, 08202 Barcelona, SpainMedical Oncology Clinical Trials Office, Vall d’Hebron Institute of Oncology, Vall d´Hebron University Hospital, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainME/CFS Research Unit, Division of Rheumatology, Vall d’Hebron Hospital Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainME/CFS Research Unit, Division of Rheumatology, Vall d’Hebron Hospital Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, SpainMyalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multisystem, and profoundly debilitating neuroimmune disease, probably of post-viral multifactorial etiology. Unfortunately, no accurate diagnostic or laboratory tests have been established, nor are any universally effective approved drugs currently available for its treatment. This study aimed to examine whether oral coenzyme Q10 and NADH (reduced form of nicotinamide adenine dinucleotide) co-supplementation could improve perceived fatigue, unrefreshing sleep, and health-related quality of life in ME/CFS patients. A 12-week prospective, randomized, double-blind, placebo-controlled trial was conducted in 207 patients with ME/CFS, who were randomly allocated to one of two groups to receive either 200 mg of CoQ10 and 20 mg of NADH (<i>n</i> = 104) or matching placebo (<i>n</i> = 103) once daily. Endpoints were simultaneously evaluated at baseline, and then reassessed at 4- and 8-week treatment visits and four weeks after treatment cessation, using validated patient-reported outcome measures. A significant reduction in cognitive fatigue perception and overall FIS-40 score (<i>p</i> < 0.001 and <i>p</i> = 0.022, respectively) and an improvement in HRQoL (health-related quality of life (SF-36)) (<i>p</i> < 0.05) from baseline were observed within the experimental group over time. Statistically significant differences were also shown for sleep duration at 4 weeks and habitual sleep efficiency at 8 weeks in follow-up visits from baseline within the experimental group (<i>p</i> = 0.018 and <i>p</i> = 0.038, respectively). Overall, these findings support the use of CoQ10 plus NADH supplementation as a potentially safe therapeutic option for reducing perceived cognitive fatigue and improving the health-related quality of life in ME/CFS patients. Future interventions are needed to corroborate these clinical benefits and also explore the underlying pathomechanisms of CoQ10 and NADH administration in ME/CFS.https://www.mdpi.com/2072-6643/13/8/2658chronic fatigue syndromecoenzyme Q10myalgic encephalomyelitismitochondrianonrestorative sleepNADH |
| spellingShingle | Jesús Castro-Marrero Maria Jose Segundo Marcos Lacasa Alba Martinez-Martinez Ramon Sanmartin Sentañes Jose Alegre-Martin Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial Nutrients chronic fatigue syndrome coenzyme Q10 myalgic encephalomyelitis mitochondria nonrestorative sleep NADH |
| title | Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial |
| title_full | Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial |
| title_fullStr | Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial |
| title_full_unstemmed | Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial |
| title_short | Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial |
| title_sort | effect of dietary coenzyme q10 plus nadh supplementation on fatigue perception and health related quality of life in individuals with myalgic encephalomyelitis chronic fatigue syndrome a prospective randomized double blind placebo controlled trial |
| topic | chronic fatigue syndrome coenzyme Q10 myalgic encephalomyelitis mitochondria nonrestorative sleep NADH |
| url | https://www.mdpi.com/2072-6643/13/8/2658 |
| work_keys_str_mv | AT jesuscastromarrero effectofdietarycoenzymeq10plusnadhsupplementationonfatigueperceptionandhealthrelatedqualityoflifeinindividualswithmyalgicencephalomyelitischronicfatiguesyndromeaprospectiverandomizeddoubleblindplacebocontrolledtrial AT mariajosesegundo effectofdietarycoenzymeq10plusnadhsupplementationonfatigueperceptionandhealthrelatedqualityoflifeinindividualswithmyalgicencephalomyelitischronicfatiguesyndromeaprospectiverandomizeddoubleblindplacebocontrolledtrial AT marcoslacasa effectofdietarycoenzymeq10plusnadhsupplementationonfatigueperceptionandhealthrelatedqualityoflifeinindividualswithmyalgicencephalomyelitischronicfatiguesyndromeaprospectiverandomizeddoubleblindplacebocontrolledtrial AT albamartinezmartinez effectofdietarycoenzymeq10plusnadhsupplementationonfatigueperceptionandhealthrelatedqualityoflifeinindividualswithmyalgicencephalomyelitischronicfatiguesyndromeaprospectiverandomizeddoubleblindplacebocontrolledtrial AT ramonsanmartinsentanes effectofdietarycoenzymeq10plusnadhsupplementationonfatigueperceptionandhealthrelatedqualityoflifeinindividualswithmyalgicencephalomyelitischronicfatiguesyndromeaprospectiverandomizeddoubleblindplacebocontrolledtrial AT josealegremartin effectofdietarycoenzymeq10plusnadhsupplementationonfatigueperceptionandhealthrelatedqualityoflifeinindividualswithmyalgicencephalomyelitischronicfatiguesyndromeaprospectiverandomizeddoubleblindplacebocontrolledtrial |